Stable composition comprising a PTHrP analogue
US8148333B2 · kind B2 · utility
20Cited by
23References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 3, 2007 |
| Grant date | Apr 3, 2012 |
| Priority date | — |
| Expiry date | Nov 8, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) analogue and methods of using a PTHrP analogue and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.